XEPI Trademark

Trademark Overview

On Monday, March 5, 2018, a trademark application was filed for XEPI with the United States Patent and Trademark Office. The USPTO has given the XEPI trademark a serial number of 87820029. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Saturday, June 7, 2025. This trademark is owned by Medimetriks Pharmaceuticals, Inc.. The XEPI trademark is filed in the Pharmaceutical Products category with the following description:

Topical pharmaceutical preparation for dermatologic use in treating skin disorders
xepi

General Information

Serial Number87820029
Word MarkXEPI
Filing DateMonday, March 5, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateSaturday, June 7, 2025
Registration Number5699059
Registration DateTuesday, March 12, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Description of MarkThe mark consists of a semicircle design made of small rectangles. The left half of the semicircle is purple and the right half is orange. The word "XEPI" is beneath the semicircle in black lettering.
Goods and ServicesTopical pharmaceutical preparation for dermatologic use in treating skin disorders
Indication of Colors claimedThe color(s) black, purple and orange is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 10, 2018
Primary Code005
First Use Anywhere DateWednesday, October 31, 2018
First Use In Commerce DateWednesday, October 31, 2018

Trademark Owner History

Party NameFERRER INTERNACIONAL S.A.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBarcelona 08028
ES
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004

Trademark Events

Event DateEvent Description
Monday, June 18, 2018ASSIGNED TO EXAMINER
Thursday, March 8, 2018NEW APPLICATION ENTERED
Saturday, March 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 13, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 19, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, December 19, 2018USE AMENDMENT FILED
Wednesday, January 23, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 5, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 6, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 12, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, March 27, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 24, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 20, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 28, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 28, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 24, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 20, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, September 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 16, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 23, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, September 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 27, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, June 7, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, June 7, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, February 20, 2025TEAS SECTION 8 RECEIVED

Related Keywords

xepi skin disorders treating dermatologic pharmaceutical preparation topical